Therefore, ATM-derived IL-10 may be a promising indicator to monitor HGP homeostasis during fasting-feeding cycle and a potential therapeutic target for obesity-induced metabolic dysfunction. The gene discussed is IL10; the disease is obesity due to melanocortin 4 receptor deficiency.